Aurinia Pharmaceuticals Inc. Other Non-Current Liabilities
Aurinia Pharmaceuticals Inc. (AUPH) had Other Non-Current Liabilities of $945.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $945.00K.
- 2026-03-31: Other Liabilities, Noncurrent $6.90M.
- 2025-12-31: Other Liabilities, Noncurrent $6.66M; Other Liabilities, Noncurrent as first filed $6.70M.
- 2025-09-30: Other Liabilities, Noncurrent $12.40M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $945.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $6.90M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $6.66M 10-Q · filed 2026-08-06 | $6.70M 10-K · filed 2026-02-26 |
| 2025-09-30 | $12.40M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $12.00M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $11.40M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $9.40M 10-K · filed 2026-02-26 | $11.11M 10-K · filed 2025-02-27 |
| 2024-09-30 | $10.84M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $10.94M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $12.29M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $10.91M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $10.34M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $8.71M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $12.32M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $12.17M 10-K · filed 2024-02-15 | |
| 2022-09-30 | $15.83M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $16.32M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $17.38M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $15.95M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $16.56M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $16.87M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $17.89M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $16.30M 10-K · filed 2022-02-28 | $1.59M 10-K · filed 2021-02-24 |
| 2019-12-31 | $6.21M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B |